Colette Cywes-Bentley, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acetylglucosamine | 11 | 2021 | 191 | 2.180 |
Why?
|
| Antibodies, Bacterial | 16 | 2023 | 1470 | 1.700 |
Why?
|
| Actinomycetales Infections | 6 | 2021 | 30 | 1.600 |
Why?
|
| Rhodococcus equi | 6 | 2021 | 16 | 1.130 |
Why?
|
| Bacterial Vaccines | 5 | 2021 | 403 | 1.070 |
Why?
|
| Horse Diseases | 6 | 2021 | 57 | 0.860 |
Why?
|
| Polysaccharides, Bacterial | 8 | 2019 | 578 | 0.630 |
Why?
|
| Staphylococcus aureus | 8 | 2018 | 1453 | 0.600 |
Why?
|
| Bacterial Capsules | 7 | 2015 | 251 | 0.570 |
Why?
|
| Streptococcus pyogenes | 6 | 2003 | 289 | 0.500 |
Why?
|
| Horses | 8 | 2021 | 304 | 0.460 |
Why?
|
| Antigens, Bacterial | 2 | 2018 | 1172 | 0.450 |
Why?
|
| Immunization, Passive | 3 | 2021 | 623 | 0.430 |
Why?
|
| Streptococcal Infections | 6 | 2020 | 638 | 0.370 |
Why?
|
| Mycoses | 1 | 2013 | 376 | 0.360 |
Why?
|
| Pneumonia, Bacterial | 3 | 2021 | 316 | 0.360 |
Why?
|
| Bacterial Infections | 2 | 2018 | 1401 | 0.330 |
Why?
|
| Bacterial Adhesion | 4 | 2007 | 316 | 0.320 |
Why?
|
| Hyaluronic Acid | 4 | 2006 | 491 | 0.280 |
Why?
|
| beta-Glucans | 3 | 2018 | 123 | 0.270 |
Why?
|
| Opsonin Proteins | 5 | 2019 | 150 | 0.240 |
Why?
|
| Streptococcus equi | 2 | 2020 | 9 | 0.240 |
Why?
|
| Bacterial Proteins | 8 | 2021 | 3854 | 0.230 |
Why?
|
| Animals, Newborn | 5 | 2021 | 2726 | 0.220 |
Why?
|
| Malaria | 1 | 2013 | 1239 | 0.220 |
Why?
|
| Complement C1 | 2 | 2019 | 33 | 0.220 |
Why?
|
| Meningitis, Bacterial | 1 | 2023 | 218 | 0.190 |
Why?
|
| Immunoglobulin G | 3 | 2019 | 4561 | 0.190 |
Why?
|
| Coagulase | 2 | 2012 | 54 | 0.190 |
Why?
|
| Virulence Factors | 3 | 2019 | 509 | 0.180 |
Why?
|
| Bacteria | 3 | 2023 | 2115 | 0.180 |
Why?
|
| Escherichia coli | 4 | 2023 | 4217 | 0.170 |
Why?
|
| Biofilms | 4 | 2018 | 617 | 0.170 |
Why?
|
| Pharynx | 2 | 2001 | 413 | 0.170 |
Why?
|
| Neutrophil Activation | 1 | 2019 | 186 | 0.160 |
Why?
|
| Immunization | 3 | 2020 | 1256 | 0.160 |
Why?
|
| Phagocytosis | 4 | 2019 | 1539 | 0.160 |
Why?
|
| Intestines | 2 | 2019 | 1924 | 0.160 |
Why?
|
| Vaccination | 3 | 2021 | 3279 | 0.160 |
Why?
|
| Vaccines, Conjugate | 3 | 2018 | 333 | 0.160 |
Why?
|
| Staphylococcal Infections | 5 | 2018 | 1400 | 0.150 |
Why?
|
| Transport Vesicles | 1 | 2018 | 83 | 0.150 |
Why?
|
| Enterococcus faecalis | 1 | 2019 | 251 | 0.150 |
Why?
|
| Fungal Vaccines | 1 | 2016 | 7 | 0.140 |
Why?
|
| Antibodies, Monoclonal | 3 | 2019 | 9274 | 0.130 |
Why?
|
| Pneumonia, Staphylococcal | 1 | 2015 | 43 | 0.130 |
Why?
|
| Malaria Vaccines | 1 | 2016 | 158 | 0.120 |
Why?
|
| Enterobacteriaceae | 1 | 2016 | 169 | 0.120 |
Why?
|
| Escherichia coli Vaccines | 1 | 2014 | 11 | 0.120 |
Why?
|
| Animals | 28 | 2023 | 168768 | 0.120 |
Why?
|
| Keratinocytes | 5 | 2003 | 799 | 0.120 |
Why?
|
| Shiga Toxin | 1 | 2014 | 34 | 0.120 |
Why?
|
| Shiga-Toxigenic Escherichia coli | 1 | 2014 | 28 | 0.120 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2016 | 187 | 0.120 |
Why?
|
| Eye Infections | 1 | 2014 | 64 | 0.120 |
Why?
|
| beta-Lactamases | 1 | 2016 | 306 | 0.120 |
Why?
|
| Antigens, Surface | 1 | 2018 | 1663 | 0.110 |
Why?
|
| Galactans | 1 | 2012 | 31 | 0.110 |
Why?
|
| Yersinia pestis | 1 | 2012 | 33 | 0.110 |
Why?
|
| Burkholderia cepacia complex | 1 | 2012 | 25 | 0.100 |
Why?
|
| Gram-Positive Bacteria | 1 | 2013 | 185 | 0.100 |
Why?
|
| Plasmodium berghei | 1 | 2013 | 168 | 0.100 |
Why?
|
| Bacillus subtilis | 1 | 2015 | 359 | 0.100 |
Why?
|
| Burkholderia Infections | 1 | 2012 | 44 | 0.100 |
Why?
|
| Gene Expression Regulation, Bacterial | 2 | 2012 | 1122 | 0.100 |
Why?
|
| Gram-Negative Bacteria | 1 | 2013 | 271 | 0.100 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2015 | 567 | 0.100 |
Why?
|
| Mice | 18 | 2023 | 81201 | 0.100 |
Why?
|
| Fungi | 1 | 2013 | 327 | 0.090 |
Why?
|
| Escherichia coli Infections | 1 | 2014 | 532 | 0.090 |
Why?
|
| Eye | 1 | 2014 | 729 | 0.090 |
Why?
|
| Pneumonia | 1 | 2021 | 2133 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 7 | 2019 | 21833 | 0.080 |
Why?
|
| Adaptive Immunity | 1 | 2014 | 714 | 0.080 |
Why?
|
| Microscopy, Confocal | 4 | 2012 | 1970 | 0.080 |
Why?
|
| Fibrinogen | 2 | 2012 | 894 | 0.080 |
Why?
|
| Graft vs Host Disease | 1 | 2019 | 2958 | 0.070 |
Why?
|
| Streptococcus | 1 | 2006 | 197 | 0.070 |
Why?
|
| Phospholipases A | 1 | 2006 | 216 | 0.070 |
Why?
|
| Streptolysins | 2 | 2003 | 55 | 0.070 |
Why?
|
| Aminoquinolines | 1 | 2004 | 109 | 0.060 |
Why?
|
| Host-Pathogen Interactions | 1 | 2013 | 1480 | 0.060 |
Why?
|
| Bacteriophages | 1 | 2006 | 356 | 0.060 |
Why?
|
| Protein Binding | 2 | 2013 | 9384 | 0.050 |
Why?
|
| Neutrophils | 4 | 2019 | 3721 | 0.050 |
Why?
|
| Genome, Bacterial | 2 | 2019 | 760 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2004 | 4424 | 0.050 |
Why?
|
| NAD+ Nucleosidase | 1 | 2002 | 39 | 0.050 |
Why?
|
| Streptococcus agalactiae | 1 | 2003 | 375 | 0.050 |
Why?
|
| Intercellular Junctions | 1 | 2001 | 203 | 0.050 |
Why?
|
| Fasciitis, Necrotizing | 1 | 2001 | 79 | 0.050 |
Why?
|
| Molecular Mimicry | 1 | 2001 | 201 | 0.050 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2001 | 237 | 0.050 |
Why?
|
| Complement System Proteins | 1 | 2003 | 795 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2015 | 6542 | 0.050 |
Why?
|
| Interleukins | 2 | 2015 | 791 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2013 | 10252 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 2 | 2019 | 6386 | 0.040 |
Why?
|
| Lipoproteins | 1 | 2004 | 878 | 0.040 |
Why?
|
| Virulence | 2 | 2019 | 1333 | 0.040 |
Why?
|
| Injections, Intramuscular | 1 | 2020 | 552 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2001 | 23404 | 0.040 |
Why?
|
| Imidazoles | 1 | 2004 | 1206 | 0.040 |
Why?
|
| Carbohydrate Conformation | 1 | 2018 | 209 | 0.040 |
Why?
|
| Fetal Blood | 1 | 2004 | 1318 | 0.040 |
Why?
|
| Monocytes | 2 | 2004 | 2596 | 0.040 |
Why?
|
| Abdominal Abscess | 1 | 1999 | 154 | 0.040 |
Why?
|
| Surgical Wound Infection | 1 | 2006 | 1540 | 0.040 |
Why?
|
| Immune Sera | 2 | 2012 | 641 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2004 | 2216 | 0.040 |
Why?
|
| Rabbits | 2 | 2014 | 4894 | 0.040 |
Why?
|
| Blood Platelets | 1 | 2007 | 2509 | 0.040 |
Why?
|
| Cytoskeleton | 1 | 2001 | 1185 | 0.040 |
Why?
|
| Models, Molecular | 2 | 2018 | 5451 | 0.030 |
Why?
|
| Bacterial Toxins | 1 | 2002 | 931 | 0.030 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2019 | 341 | 0.030 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2018 | 482 | 0.030 |
Why?
|
| Plasma | 1 | 2019 | 575 | 0.030 |
Why?
|
| Multilocus Sequence Typing | 1 | 2015 | 100 | 0.030 |
Why?
|
| Disease Models, Animal | 5 | 2014 | 18034 | 0.030 |
Why?
|
| Cell Membrane | 2 | 2004 | 3749 | 0.030 |
Why?
|
| Immune Tolerance | 1 | 2004 | 2259 | 0.030 |
Why?
|
| Mutation | 3 | 2019 | 29786 | 0.030 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 1998 | 404 | 0.030 |
Why?
|
| Antibody Specificity | 2 | 2012 | 1095 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2004 | 2865 | 0.030 |
Why?
|
| HL-60 Cells | 1 | 2015 | 365 | 0.030 |
Why?
|
| Biosynthetic Pathways | 1 | 2015 | 137 | 0.030 |
Why?
|
| Peptides | 1 | 2006 | 4410 | 0.030 |
Why?
|
| Genetic Complementation Test | 1 | 2015 | 562 | 0.030 |
Why?
|
| Cells, Cultured | 4 | 2006 | 19233 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2004 | 8436 | 0.030 |
Why?
|
| Antitoxins | 1 | 2014 | 81 | 0.030 |
Why?
|
| Bacterial Load | 1 | 2014 | 153 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 3771 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2018 | 2012 | 0.030 |
Why?
|
| Siphonaptera | 1 | 2012 | 7 | 0.030 |
Why?
|
| Immobilized Proteins | 1 | 2012 | 25 | 0.030 |
Why?
|
| Flow Cytometry | 3 | 2012 | 5974 | 0.030 |
Why?
|
| Time Factors | 2 | 2013 | 40075 | 0.030 |
Why?
|
| Congo Red | 1 | 2012 | 46 | 0.030 |
Why?
|
| Immunotherapy | 2 | 2023 | 4446 | 0.030 |
Why?
|
| Microbial Viability | 1 | 2014 | 234 | 0.030 |
Why?
|
| Female | 12 | 2021 | 380193 | 0.030 |
Why?
|
| Goats | 1 | 2012 | 171 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2001 | 2455 | 0.030 |
Why?
|
| Interleukin-2 | 1 | 1999 | 1904 | 0.030 |
Why?
|
| Blood Bactericidal Activity | 1 | 2012 | 126 | 0.030 |
Why?
|
| Chromatography, Gel | 1 | 2012 | 668 | 0.030 |
Why?
|
| Humans | 18 | 2019 | 744366 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2015 | 1202 | 0.020 |
Why?
|
| Color | 1 | 2012 | 307 | 0.020 |
Why?
|
| Phagocytes | 1 | 2012 | 297 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2023 | 3595 | 0.020 |
Why?
|
| Culture Media | 1 | 2012 | 909 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2014 | 1159 | 0.020 |
Why?
|
| Models, Immunological | 1 | 2012 | 527 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2018 | 4010 | 0.020 |
Why?
|
| Male | 9 | 2021 | 350115 | 0.020 |
Why?
|
| Swine | 1 | 2019 | 5918 | 0.020 |
Why?
|
| Sepsis | 2 | 2003 | 2593 | 0.020 |
Why?
|
| Escherichia coli Proteins | 1 | 2015 | 1050 | 0.020 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2012 | 1369 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2006 | 7182 | 0.020 |
Why?
|
| Phylogeny | 1 | 2015 | 2804 | 0.020 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2016 | 1035 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2015 | 974 | 0.020 |
Why?
|
| Interleukin-17 | 1 | 2014 | 901 | 0.020 |
Why?
|
| Skin | 1 | 2001 | 4372 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 3848 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2000 | 9735 | 0.020 |
Why?
|
| Drug Discovery | 1 | 2016 | 1058 | 0.020 |
Why?
|
| Phospholipases A2 | 1 | 2006 | 203 | 0.020 |
Why?
|
| Colony Count, Microbial | 1 | 2006 | 331 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2015 | 1939 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2012 | 2377 | 0.020 |
Why?
|
| Temperature | 1 | 2012 | 2204 | 0.020 |
Why?
|
| Methicillin Resistance | 1 | 2006 | 198 | 0.020 |
Why?
|
| Cornea | 1 | 2014 | 1524 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2014 | 4386 | 0.020 |
Why?
|
| Bacteremia | 1 | 2012 | 963 | 0.020 |
Why?
|
| Interferon Inducers | 1 | 2004 | 25 | 0.020 |
Why?
|
| Membrane Fusion | 1 | 2006 | 276 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 1998 | 5023 | 0.020 |
Why?
|
| Ligands | 2 | 2004 | 3282 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2014 | 1978 | 0.010 |
Why?
|
| Integrin alphaXbeta2 | 1 | 2003 | 29 | 0.010 |
Why?
|
| Complement Factor B | 1 | 2003 | 72 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 4805 | 0.010 |
Why?
|
| Macrophage-1 Antigen | 1 | 2003 | 290 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 2 | 2001 | 2700 | 0.010 |
Why?
|
| Serum | 1 | 2003 | 214 | 0.010 |
Why?
|
| Age Factors | 1 | 2019 | 18373 | 0.010 |
Why?
|
| Complement C3 | 1 | 2003 | 461 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 697 | 0.010 |
Why?
|
| Soft Tissue Infections | 1 | 2003 | 155 | 0.010 |
Why?
|
| Genotype | 1 | 2015 | 12952 | 0.010 |
Why?
|
| Toll-Like Receptors | 1 | 2004 | 593 | 0.010 |
Why?
|
| Operon | 1 | 2001 | 363 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 2001 | 462 | 0.010 |
Why?
|
| Hemolysis | 1 | 2003 | 420 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2006 | 1877 | 0.010 |
Why?
|
| Peritoneum | 1 | 2001 | 228 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 7914 | 0.010 |
Why?
|
| Papio | 1 | 2001 | 656 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 1284 | 0.010 |
Why?
|
| Respiratory Tract Infections | 1 | 2006 | 961 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 1999 | 425 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2001 | 853 | 0.010 |
Why?
|
| Adhesins, Bacterial | 1 | 1998 | 119 | 0.010 |
Why?
|
| Solubility | 1 | 1999 | 1088 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2001 | 1547 | 0.010 |
Why?
|
| Plasmids | 1 | 2002 | 2308 | 0.010 |
Why?
|
| Adoptive Transfer | 1 | 1999 | 844 | 0.010 |
Why?
|
| Lung | 1 | 2015 | 9857 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 4320 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2001 | 2088 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1999 | 1892 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2003 | 2751 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 13814 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 10943 | 0.010 |
Why?
|
| Kinetics | 1 | 2002 | 6476 | 0.010 |
Why?
|
| Child | 1 | 2001 | 77709 | 0.010 |
Why?
|
| DNA Primers | 1 | 1998 | 2891 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 18111 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2001 | 3773 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2004 | 2962 | 0.010 |
Why?
|
| Survival Rate | 1 | 2006 | 12788 | 0.010 |
Why?
|
| Cell Survival | 1 | 2002 | 5882 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2001 | 5867 | 0.010 |
Why?
|
| Transfection | 1 | 1998 | 5895 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1999 | 6621 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1998 | 6171 | 0.010 |
Why?
|
| Base Sequence | 1 | 1998 | 12797 | 0.000 |
Why?
|
| Apoptosis | 1 | 2002 | 9724 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 2004 | 25628 | 0.000 |
Why?
|
| Cytokines | 1 | 1999 | 7323 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1999 | 13035 | 0.000 |
Why?
|
| Rats | 1 | 1999 | 24252 | 0.000 |
Why?
|
| Adult | 2 | 2004 | 214052 | 0.000 |
Why?
|